4//SEC Filing
CLARKE JOHN K 4
Accession 0001209191-21-029117
CIK 0001339970other
Filed
Apr 28, 8:00 PM ET
Accepted
Apr 29, 8:02 PM ET
Size
5.4 KB
Accession
0001209191-21-029117
Insider Transaction Report
Form 4
aTYR PHARMA INCLIFE
CLARKE JOHN K
DirectorOther
Transactions
- Award
Stock Option (right to buy)
2021-04-28+1,428→ 1,428 totalExercise: $4.21Exp: 2031-04-28→ Common Stock (1,428 underlying)
Footnotes (1)
- [F1]The option, granted pursuant to the Issuer's non-employee director compensation policy, vests in full on the earlier of (i) April 28, 2022 or (ii) the Issuer's 2022 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors.
Documents
Issuer
aTYR PHARMA INC
CIK 0001339970
Entity typeother
Related Parties
1- filerCIK 0001219015
Filing Metadata
- Form type
- 4
- Filed
- Apr 28, 8:00 PM ET
- Accepted
- Apr 29, 8:02 PM ET
- Size
- 5.4 KB